4//SEC Filing
Hedrick Eric 4
Accession 0001104659-23-001113
CIK 0001843762other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 9:55 PM ET
Size
6.1 KB
Accession
0001104659-23-001113
Insider Transaction Report
Form 4
EQRx, Inc.EQRX
Hedrick Eric
Chief Physician Executive
Transactions
- Award
Earn-out Shares
2023-01-01+543→ 103,612 totalExp: 2024-12-17→ Common Stock (543 underlying)
Footnotes (1)
- [F1]On January 1, 2023, the Reporting Person was allocated the right to acquire an additional 543 shares of the Issuer's Common Stock (the "Earn-out Shares"), (i) 380 of which will be released from escrow if the value weighted average price ("VWAP") for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $12.50; and (ii) 163 of which will be released from such escrow if the VWAP for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $16.50. Any Earn-out Shares not eligible to be released on or prior to December 17, 2024 will be forfeited and cancelled, and the maximum number of Earn-out Shares the Reporting Person may be eligible to acquire is subject to adjustment per the terms of the Agreement and Plan of Merger dated August 5, 2021 by and among the Issuer (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx, Inc.).
Documents
Issuer
EQRx, Inc.
CIK 0001843762
Entity typeother
Related Parties
1- filerCIK 0001502677
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 9:55 PM ET
- Size
- 6.1 KB